Jackson J E, Bentley J B, Glass S J, Fukui T, Gandolfi A J, Plachetka J R
Clin Pharmacol Ther. 1985 May;37(5):544-8. doi: 10.1038/clpt.1985.86.
The hypothesis that the H2-receptor blockers cimetidine and ranitidine have different effects on the disposition of lidocaine, a microsomally metabolized drug dependent on hepatic blood flow for elimination, was tested. Six normal men received lidocaine infusions (2 mg/kg over 10 minutes) and lidocaine levels were determined by HPLC. Lidocaine kinetics were studied in the untreated state (O) and in a double-blind, double-dummy design after 2 days of placebo (P), cimetidine (C, 300 mg every 6 hours by mouth), or ranitidine (R, 160 mg every 12 hours by mouth). Model-independent kinetics were estimated by the statistical moment theory. The steady-state volume of distribution was lower after cimetidine (means +/- SD: O, 156 +/- 39 L; P, 156 +/- 48 L; C, 123 +/- 20 L; and R, 174 +/- 38 L). A trend toward decreased lidocaine clearance after cimetidine was also noted (O, 1011 +/- 140 ml/min; P, 1087 +/- 227 ml/min; C, 886 +/- 214 ml/min; and R, 1143 +/- 225 ml/min). Elimination rate constants were of the same order in all four treatments. Only higher levels of alpha 1-acid glycoprotein appeared to limit the lidocaine steady-state volume of distribution. Cimetidine and ranitidine have distinctly different effects on lidocaine kinetics in normal subjects. The absence of ranitidine effects on the disposition of lidocaine, a high-extraction, high-clearance drug, suggests that H2-receptor blockade may not decrease hepatic blood flow, and that cimetidine impairs drug elimination only by inhibition of hepatic microsomal enzymes. Such interactions are not likely to occur with ranitidine.
有人提出一种假说,即H2受体阻滞剂西咪替丁和雷尼替丁对利多卡因的处置有不同影响,利多卡因是一种经微粒体代谢且依赖肝血流进行清除的药物,对此假说进行了验证。6名正常男性接受利多卡因输注(10分钟内输注2mg/kg),并通过高效液相色谱法测定利多卡因水平。在未治疗状态(O)以及在服用安慰剂(P)、西咪替丁(C,口服,每6小时300mg)或雷尼替丁(R,口服,每12小时160mg)2天后采用双盲、双模拟设计研究利多卡因动力学。通过统计矩理论估算不依赖模型的动力学参数。西咪替丁治疗后稳态分布容积较低(均值±标准差:O组,156±39L;P组,156±48L;C组,123±20L;R组,174±38L)。还注意到西咪替丁治疗后利多卡因清除率有降低趋势(O组,1011±140ml/min;P组,1087±227ml/min;C组,886±214ml/min;R组,1143±225ml/min)。在所有四种治疗中消除速率常数处于同一水平。仅α1 - 酸性糖蛋白水平升高似乎限制了利多卡因的稳态分布容积。西咪替丁和雷尼替丁对正常受试者利多卡因动力学有明显不同影响。雷尼替丁对高摄取、高清除药物利多卡因的处置无影响,这表明H2受体阻断可能不会降低肝血流,且西咪替丁仅通过抑制肝微粒体酶来损害药物清除。雷尼替丁不太可能发生此类相互作用。